Answers are grounded in this paper and cite their sources.
With the introduction of intermittently scanned continuous glucose monitoring (CGM) systems to the marketplace, providers and patients now have several options to continuously monitor glucose levels. This article addresses appropriate patient selection criteria for using patient- or practice-based CGM systems and the barriers to achieving optimal benefits from this technology. The authors have developed a flowchart to guide clinicians and patients in decision-making regarding the most appropriate type of CGM to use in various circumstances.
No takes yet. Share an insight, caveat, or question.
Longo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: